Arterial Ischaemic Stroke, a more user friendly and accessible treatment modality.
Am I the only one who sees this as exciting?
Up till now the market opportunities are narrow.
This is another move to force open the rusty door leading to a massively big room.
Not yet locked in. Not yet guaranteed.
But I AM excited.
- Forums
- ASX - By Stock
- CUV
- Ann: PRENUMBRA formulation completed for clinical trial use
Ann: PRENUMBRA formulation completed for clinical trial use, page-2
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CUV (ASX) to my watchlist
|
|||||
Last
$13.87 |
Change
-0.180(1.28%) |
Mkt cap ! $695.5M |
Open | High | Low | Value | Volume |
$14.00 | $14.11 | $13.75 | $452.7K | 32.48K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 275 | $13.87 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.89 | 177 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 496 | 13.870 |
3 | 170 | 13.860 |
4 | 213 | 13.850 |
3 | 659 | 13.840 |
4 | 1814 | 13.830 |
Price($) | Vol. | No. |
---|---|---|
13.890 | 330 | 7 |
13.900 | 132 | 3 |
13.910 | 47 | 1 |
13.920 | 158 | 4 |
13.930 | 107 | 3 |
Last trade - 12.35pm 20/08/2024 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |